BD MAX Clostridium difficile detection reagent - Taiwan Registration 40a3a60ba236d90d00708818c06477a7
Access comprehensive regulatory information for BD MAX Clostridium difficile detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 40a3a60ba236d90d00708818c06477a7 and manufactured by Benex Limited;; GeneOhm Sciences Canada, ULC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including BECTON DICKINSON AND COMPANY;; GeneOhm Sciences Canada, ULC., GENEOHM SCIENCES CANADA, INC., and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
40a3a60ba236d90d00708818c06477a7
DHA05603110901
Product Details
Used with the BD MAX System, this product is an automated in vitro diagnostic reagent for the direct qualitative detection of Clostridium difficile toxin B gene (tcdB) in human fluid stool or soft stool samples from patients suspected of Clostridium difficile infection (CDI). This is a test performed directly on the sample using real-time polymerase chain reaction (PCR) to amplify the DNA DNA of the Clostridium difficile toxin B gene and detect amplified DNA with fluorescent target-specific hybridization probes.
C Immunology and microbiology
C.3130 ๅฐ้ฃๆขญ็ๆกฟ่ๆฏ็ด ๅบๅ ๆดๅข่ฉฆๅ
import
Dates and Status
May 12, 2018
May 12, 2028
BD MAX Clostridium difficile detection reagent
BECTON DICKINSON AND COMPANY;; GeneOhm Sciences Canada, ULC.
35dbd32b56bcbcfc16bfa3d6d19880ca
2
BD MAX Clostridium difficile detection reagent (unsterilized)
GENEOHM SCIENCES CANADA, INC.
3c42e43d9580ec6b88a2855af21add3d
1